Related Experiment Videos
Recanalization therapies for acute ischemic stroke
1Department of Neurology, University of Cincinnati Medical Center, Ohio, USA.
Seminars in Neurology
|February 5, 1999
Summary
Intravenous tissue plasminogen activator (t-PA) effectively treats acute ischemic stroke within 3 hours. Intra-arterial therapies show promise for larger clots but require further research on safety and long-term outcomes.
Area of Science:
- Neurology
- Vascular Medicine
- Interventional Radiology
Background:
- Acute ischemic stroke often involves visible arterial occlusions.
- Intravenous tissue plasminogen activator (t-PA) is effective within 3 hours of stroke onset.
- Effectiveness and safety of t-PA beyond 3 hours are not established.
Purpose of the Study:
- To review current thrombolytic therapies for acute ischemic stroke.
- To compare the efficacy of intravenous versus intra-arterial thrombolysis.
- To explore future strategies for clot lysis and recanalization.
Main Methods:
- Review of angiographic studies and clinical trial data (NINDS t-PA Stroke Study).
- Comparison of recanalization rates and times for different thrombolytic delivery methods.
- Discussion of emerging technologies and combination therapies.
Main Results:
- Intravenous t-PA effectively lyses clots within 3 hours.
- Intra-arterial thrombolysis may be more effective for large clots but takes longer.
- Head-to-head comparisons and long-term outcome data are lacking for intra-arterial therapy.
Conclusions:
- Intra-arterial delivery and combination therapies warrant further investigation.
- Advances in catheter technology are needed for effective cerebral clot lysis.
- Balancing recanalization efficacy with intracerebral hemorrhage risk is crucial for future treatments.